United States - English - NLM (National Library of Medicine)

pfizer laboratories div pfizer inc - epoetin (unii: 64fs3bfh5w) (erythropoietin - unii:64fs3bfh5w) - retacrit is indicated for the treatment of anemia due to chronic kidney disease (ckd), including patients on dialysis and not on dialysis to decrease the need for red blood cell (rbc) transfusion. retacrit is indicated for the treatment of anemia due to zidovudine administered at ≤ 4,200 mg/week in patients with hiv-infection with endogenous serum erythropoietin levels of ≤ 500 munits/ml. retacrit is indicated for the treatment of anemia in patients with non-myeloid malignancies where anemia is due to the effect of concomitant myelosuppressive chemotherapy, and upon initiation, there is a minimum of two additional months of planned chemotherapy. retacrit is indicated to reduce the need for allogeneic rbc transfusions among patients with perioperative hemoglobin > 10 to ≤ 13 g/dl who are at high risk for perioperative blood loss from elective, noncardiac, nonvascular surgery. retacrit is not indicated for patients who are willing to donate autologous blood pre-operatively. retacrit has not been shown to improv

United States - English - NLM (National Library of Medicine)

vifor (international) inc. - epoetin (unii: 64fs3bfh5w) (epoetin - unii:64fs3bfh5w) - retacrit is indicated for the treatment of anemia due to chronic kidney disease (ckd), including patients on dialysis and not on dialysis to decrease the need for red blood cell (rbc) transfusion. retacrit is indicated for the treatment of anemia due to zidovudine administered at ≤ 4,200 mg/week in patients with hiv-infection with endogenous serum erythropoietin levels of ≤ 500 munits/ml. retacrit is indicated for the treatment of anemia in patients with non-myeloid malignancies where anemia is due to the effect of concomitant myelosuppressive chemotherapy, and upon initiation, there is a minimum of two additional months of planned chemotherapy. retacrit is indicated to reduce the need for allogeneic rbc transfusions among patients with perioperative hemoglobin > 10 to ≤ 13 g/dl who are at high risk for perioperative blood loss from elective, noncardiac, nonvascular surgery. retacrit is not indicated for patients who are willing to donate autologous blood pre-operatively. retacrit has not been shown to improv

Israel - English - Ministry of Health

tec-o-pharm-libra ltd - tramadol hydrochloride - tablets extended release - tramadol hydrochloride 100 mg - tramadol - tramadol - moderate to severe pain.

Ireland - English - HPRA (Health Products Regulatory Authority)

bayer limited - nifedipine - tablet prolonged release - 10 mg milligram - nifedipine

Ireland - English - HPRA (Health Products Regulatory Authority)

bayer limited - nifedipine - tablet prolonged release - 20 mg milligram - nifedipine

Malta - English - Medicines Authority

meda manufacturing gmbh d-51010 cologne, germany - acemetacin - hard capsule prolonged-release capsule - acemetacin 90 mg - antiinflammatory and antirheumatic products

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

bayer plc - nifedipine - modified-release tablet - 10mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

bayer plc - nifedipine - modified-release tablet - 20mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

sanofi - diltiazem hydrochloride - modified-release tablet - 90mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

sanofi - diltiazem hydrochloride - modified-release tablet - 120mg